Articles related to DEVICE/DRUG APPROVALS

The FDA’s approval of Beyfortus offers a promising tool for RSV disease prevention in neonates and young children. This novel intervention, underscored by robust clinical trial data, marks a crucial stride towards protecting infant health in the US.

Brenzavvy, the latest addition to the diabetes treatment landscape, promises a cost-effective approach to managing type 2 diabetes. Discover how this newly approved drug could redefine the treatment paradigm for patients.

FDA’s approval of Opill, the first over-the-counter daily oral contraceptive, marks a major shift in contraceptive accessibility, opening new pathways in the prevention of unintended pregnancies.

As the FDA approves the first over-the-counter oral contraceptive, dental professionals must be cognizant of potential impacts on oral health and patient management.

Discover how Overjet’s AI technology, with its fourth FDA clearance, is setting new standards in the dental industry, enhancing caries detection and treatment planning for patients aged 12 and older.

The FDA-approved LODOCO is anticipated to significantly advance cardiovascular treatment, reducing cardiac events by 31% in established cardiovascular disease patients. Read about the innovative research that has led to this breakthrough in patient care.